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The asparaginyl-tRNA synthetase-like SlgZ and methyltransferase SlgM enzymes are involved in the bio-
synthesis of the tetramic acid streptolydigin in Streptomyces lydicus. Inactivation of slgZ led to a novel strep-
tolydigin derivative. Overexpression of slgZ, slgM, or both in S. lydicus led to a considerable increase in
streptolydigin production.
Hybrid polyketide-nonribosomal peptide compound strep-
tolydigin (Fig. 1A), produced by Streptomyces lydicus, is a mem-
ber of the tetramic acid family (21). It is a potent inhibitor of
bacterial RNA polymerase (RNAP) (20, 22, 23). In addition,
streptolydigin has been shown to inhibit terminal deoxynucleo-
tidyltransferase, an enzyme found in large amounts in leuko-
cytes from patients with acute lymphoblastic leukemia or with
rare cases of acute and chronic myelocytic leukemia (6, 7). The
streptolydigin biosynthesis gene cluster from S. lydicus
NRRL2433 has been recently characterized, and the involve-
ment of a hybrid polyketide synthase (PKS)/nonribosomal pep-
tide synthetase (NRPS) system has been confirmed. In addi-
tion, genes encoding proteins involved in secretion, pathway
regulation, tailoring modification, and precursor supply were
identified (16). Among the precursor supply-associated genes,
slgZ and slgM, encoding an asparaginyl-tRNA synthetase like
enzyme and a methyltransferase, respectively, have been pro-
posed to be involved in the tailoring modification of precursor
3-methyl-aspartate (16). In this communication, we provide
further experimental evidence of the role of these two genes in
precursor supply for streptolydigin biosynthesis.
SlgZ shows similarity to class IIb aminoacyl-tRNA synthe-
tases. However, this was a surprising finding, since, apparently,
no aminoacyl-tRNA synthetase was anticipated to be necessary
for streptolydigin biosynthesis. To the best of our knowledge,
few aminoacyl-tRNA synthetases have been demonstrated to
be involved in antibiotic biosynthesis; such synthetases include
seryl-tRNA synthetase VlmL from Streptomyces viridifaciens
MG456-hF10 (8) and aminoacyl-tRNA synthetase-like cy-
clodipeptide synthases such as AlbC, which uses aminoacyl-
tRNAs as substrates to catalyze the formation of the di-
ketopiperazine peptide bonds (10). AlbC participates in the
biosynthesis of valinomycin, catalyzing the transfer of the seryl
residue from seryl-tRNA to the hydroxyl group of isobutylhy-
droxylamine (9). Nevertheless, SlgZ also shows similarity to
archaeal asparaginyl-tRNA synthetases and, in particular, to a
kind of such enzymes that contains the catalytic core of aspar-
aginyl-tRNA synthetases but lacks the N-terminal anticodon-
binding site (Fig. 1B). This kind of truncated form of aspara-
ginyl-tRNA synthetases has been shown to produce asparagine
by amidation of aspartic acid. In particular, this activity has
been demonstrated in the case of AsnRS2 from Pyrococcus
abyssi. This proved that AsnRS2 is the archaeal orthologue of
the bacterial ammonia-dependent asparagine synthetase A
(19). The role of SlgZ in streptolydigin biosynthesis was therefore
further investigated by deleting slgZ from S. lydicus by interge-
neric conjugation from Escherichia coli ET12567(pUB307) and
using pslgZHyg (Table 1). A single-crossover strain, which was
apramycin and hygromycin resistant, was grown in the absence of
antibiotic selection, and then colonies were screened for hygro-
mycin sensitivity and apramycin resistance as a consequence of a
double recombination event. This approach led to the mutant
SLMZ (Fig. 2A).
Analysis of the products accumulated by mutant SLMZ (Fig.
2B) showed a novel compound (3) with an ultrahigh-perfor-
mance liquid chromatography (UPLC) retention time of 6.1
min. Upon mass spectrometry (MS) analysis, this peak showed
two ions with m/z 587 and 473 ([M  H]), corresponding to
the unfragmented compound and the aglycon fragment ions,
respectively. The structural elucidation of this compound was
carried out using one-dimensional (1D) 1H, two-dimensional
(2D) 1H cooler synchrotron (COSY), 1H, 13C heteronuclear
single-quantum coherence (HSQC)-edited, and heteronuclear
multiple-bond correlation (HMBC) nuclear magnetic reso-
nance (NMR) experiments. This allowed us to identify the
compound as streptolydigin B, a derivative of streptolydigin
with a tetramic acid lateral side chain derived from glutamate
instead of 3-methyl-aspartate (Fig. 1A). Production of strep-
tolydigin in mutant SLMZ was restored by introduction of
plasmid pEM4TslgZ, containing slgZ under the control of the
ermE* promoter (Fig. 2B). All these experiments demonstrate
the utilization of glutamate instead of 3-methyl-aspartate as
the substrate by the streptolydigin NRPS complex and conse-
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quently show a certain degree of substrate flexibility. This
incorporation might be sustained by the 2-fold increase in the
glutamate pool of SLMZ compared with that of the S. lydicus
wild type, observed when the intracellular amino acid pools
were determined by growing the strains in a minimal medium
with NH4Cl as the nitrogen source, medium that sustains the
production of streptolydigin by S. lydicus. The analysis of glu-
tamate pools was performed by amino acid derivatization with
phenylisothiocyanate and UPLC analysis as described previ-
ously (1).
The fact that SLMZ incorporates glutamate is a clear sug-
gestion that the SlgZ protein acts as an aminotransferase,
converting 3-methyl-aspartate into 3-methyl-asparagine, in a
manner similar to that of AsnR2 of P. abyssi (19). Therefore,
we propose that SlgZ is not a classical asparaginyl-tRNA syn-
thetase but a 3-methyl-asparagine synthetase.
The antibiotic activity of streptolydigin B was tested and
compared with that of streptolydigin by a bioassay as previ-
ously described (16). Streptolydigin B showed less activity
against Streptomyces albus than streptolydigin (Fig. 2C). This
indicates that the modification of the tetramic acid lateral side
chain, and in particular the replacement of the acetamide
moiety by a carboxyl group, reduces the antibacterial activity of
this compound. This effect is supported by the observation of
the nitrogen of this moiety interacting with the Thermus ther-
mophilus RNAP  subunit Asn729 and the fact that the
RNAP is less sensitive to tirandamycin (22), which also lacks
the acetamide group.
FIG. 1. (A) Structures of streptolydigin (compound 1) and novel derivative streptolydigin B (compound 2). (B) Schematic representation of
SlgZ (S. lydicus), AsnRS2, and AsnRS (P. abyssi). A sequence comparison of three characteristic motifs present in the catalytic core is shown. The
invariant residues from each motif are indicated by black circles. (C) Supply of amino acid precursor for the biosynthesis of streptolydigin. A,
SlgN1 adenylation domain; A, SlgN2 adenylation domain; C, condensation domain; PCP, peptidyl carrier protein.
2648 NOTES J. BACTERIOL.
 o
n
 February 9, 2017 by O
VIEDO
 LIBRARY
http://jb.asm.org/
D
ow
nloaded from
 
The effect of SlgZ on the production of streptolydigin was
assessed by overexpressing the corresponding gene in the S.
lydicus wild-type strain. We used two plasmids, pEM4TslgZ
and pEM4HTslgZ (Table 1), both carrying slgZ under the
control of the ermE* promoter but each carrying a different
antibiotic marker, that for apramycin in pEM4TslgZ and that
for hygromycin in pEM4HTslgZ. Expression of slgZ by using
pEM4TslgZ had no apparent effect on streptolydigin produc-
tion, while its expression by using pEM4HTslgZ led to a 1.5-
fold increase in streptolydigin production (Fig. 2D).
SlgM is a putative methyltransferase that contains the meth-
yltransferase-11 signature domain present in S-adenosylme-
thionine (SAM)-dependent methyltransferases of this family
of enzymes (pfam 08241). An slgM mutant was generated by
gene disruption using pOJM (Table 1). Transconjugants were
selected for resistance to apramycin. Analysis of the prod-
ucts accumulated by mutant SLMM showed no production
of streptolydigin or any other derived compound (data not
shown). This was an unexpected result, since, as previously
reported, demethyl-streptolydiginone was isolated from mu-
tant SLM7H13 (16), with L-rhodinose biosynthesis genes
slgS3 to slgS7 deleted, and it was expected to be accumulated
by SLMM. Accumulation of a streptolydigin intermediate or
derivative compound would confirm the participation of
SlgM in tailoring modification, as has been the case with
other methyltransferases involved in the biosynthesis of
polyketides and nonribosomal peptide compounds (17, 18).
However, the lack of antibiotic production in mutant SLMM
is in agreement with the results obtained by inactivating
lipMt in the tetramic acid -lipomycin biosynthesis gene
cluster from Streptomyces aureofaciens Tu¨117 (3). In that
case, the lack of LipMt abolished -lipomycin production
and led to the authors of that study to propose that the
methylation event occurs on an NRPS-bound glutamic acid
substrate (3). Curiously, in the -lipomycin biosynthesis
gene cluster lipMt, lipX2, and lipNrps are organized in the
same manner as slgM, slgL, and slgN2 are in the streptoly-
digin gene cluster. The proteins encoded by these genes in each
pathway are homologues and are proposed to perform equivalent
activities (3, 16).
The absence of demethyl-streptolydiginone in cultures of
SLMM led us to propose also a bound 3-methyl-asparagine-
TABLE 1. Bacterial strains, plasmids, and primers used in this study
Strain, plasmid, or primer Description or relevant characteristicsa Reference, source, orrestriction enzyme
Strains
S. lydicus
NRRL2433 Streptolydigin producer 16
SLMZ S. lydicus with slgZ deletion; streptolydigin B producer This study
SLMM S. lydicus with slgM deletion This study
Escherichia coli
DH10B For subcloning Invitrogen
ET12567(pUB307) For S. lydicus conjugation 12
Plasmids
Slg4A8 Source of slgZ and slgM 16
pOJPM Source of slgM 16
pCR-BLUNT For initial cloning and sequencing of PCR products Invitrogen
pOJ260 Source of oriT RK2 region 2
pOJ260P For gene replacement in S. lydicus 15
pEM4T For gene expression in S. lydicus 14
pLHyg Source of hygromycin resistance gene hyg 15
pEFBA Source of apramycin resistance gene aac(3)IV 13
pEFBAoriT pEFBA containing oriT region from pOJ260 as an XbaI-SpeI fragment This study
pslgZHyg pEFBAoriT containing hyg as an SpeI-NheI fragment and PCR products HEI19/HEI20
and HEI21/HEI22 flanking aac(3)IV; used to generate mutant SLMZ
This study
pOJM pOJ260P containing PCR product CRIS15/CRIS16; used to generate mutant SLMM This study
pEM4TslgZ pEM4T containing slgZ PCR product HEI23/HEI24 This study
pEM4TslgM pEM4T containing slgM as a BamHI-EcoRI fragment from pOJPM This study
pEM4TslgZM pEM4TslgM containing slgZ as a BamHI fragment This study
pEM4HT pEM4T containing hyg as an SpeI-NheI fragment
pEM4HTslgZ pEM4TslgZ containing hyg as an SpeI-NheI fragment This study
pEM4HTslgM pEM4TslgM containing hyg as an SpeI-NheI fragment This study
pEM4HTslgZM pEM4TslgZM containing hyg as an SpeI-NheI fragment This study
Primers
HEI19 AACTAGTCCTTCACCGCCCTGGCCC SpeI
HEI20 AAAATGCATGTGAGGGCGGCAGCTGGC NsiI
HEI21 AAGGATCCCGAAGATCCCCGGCGTGG BamHI
HEI22 AAGATATCGTCGAGGAACGCGTGCGG EcoRV
CRIS15 AATCTAGAACGTGGGCGACGACACGG XbaI
CRIS16 AGAATTCCTGGTAGCCGCCGTCCG EcoRI
HEI23 AAGGATCCGGCAAGTACCGCGGCGCC BamHI
HEI24 AAGGATCCGGCAGACAGCCCGCTGCC BamHI
a Underlining in the primer sequences indicates restriction sites.
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NRPS as the substrate for the SlgM methylation event during
streptolydigin biosynthesis (Fig. 1C). This N-methylation step
might be required for the correct condensation of the amino
acid-NRPS bound to the already formed polyketide backbone.
The absence of SlgM might imply the presence of a bound
3-methyl-asparagine-NRPS (with a free amino group), thus
blocking the biosynthetic pathway (or, less probably, generat-
ing an unstable intermediate). Otherwise, if not blocked, the
streptolydigin NRPS should incorporate glutamate, thus gen-
erating streptolydigin B (as in mutant SLMZ), a compound
that is not produced by mutant SLMM. The bound 3-methyl-
asparagine-NRPS substrate might arise from the incorporation
of 3-methyl-aspartate into the NRPS, followed by its amidation
by SlgZ (Fig. 1C), since purified SlgZ retains a slight level of
aspartate amidation activity but is unable to amidate free
3-methyl-aspartate (data not shown). Production of streptoly-
digin in mutant SLMM was restored by introduction of plasmid
pEM4TslgM, containing slgM under the control of the ermE*
promoter.
Considering the positive effect of expressing slgZ in the S.
lydicus wild-type strain on streptolydigin production, the effects
of expressing slgM and both slgZ and slgM in this strain were
analyzed. The plasmids used to carry on these experiments
were pEM4TslgM, pEM4HTslgM, pEM4TslgZM, and
FIG. 2. (A) Scheme representing the replacement of slgZ in the chromosome of S. lydicus (wild type [WT]) with the apramycin resistance
cassette. aac(3)IV, apramycin resistance gene; hyg, hygromycin resistance gene; bla, -lactamase gene. (B) UPLC analysis of mutant SLMZ (upper
panel) and mutant SLMZ complemented by plasmid pEM4TslgZ (lower panel). AU, arbitrary units. (C) Antibiotic activity of streptolydigin (1)
and streptolydigin B (2) against S. albus. Each paper disk was soaked with 2 g of the corresponding compound. Control (C), without antibiotic.
(D) Effect of slgZ, slgM, and slgZ-slgM overexpression in S. lydicus on streptolydigin production. Cultures were performed on R5A solid media,
and streptolydigin production was determined by high-performance liquid chromatography (HPLC) analysis. Experiments were run in triplicate.
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pEM4HTslgZM (Table 1). The use of pEM4TslgM and
pEM4HTslgM led to moderate increases in streptolydigin pro-
duction (2- and 1.1-fold, respectively) (Fig. 2D). However, a
cooperative effect was observed by expressing slgZ and slgM by
using pEM4TslgZM and pEM4HTslgZM. These coexpression
experiments led to 3- and 2.1-fold increases in production,
respectively (Fig. 2D).
One issue remains to be clarified: the origin of demethyl-
streptolydiginone isolated and characterized from mutant
SLM7H13 (16). In this mutant, two nonglycosylated com-
pounds were isolated: demethyl-streptolydiginone and strep-
tolydiginone. The initial proposal for the streptolydigin path-
way assumed that demethyl-streptolydiginone was the
precursor of streptolydiginone to be N methylated by SlgM.
The results obtained in this work with mutant SLMM prove
that demethyl-streptolydiginone is not the substrate for SlgM.
However, demethyl-streptolydiginone could be derived from
streptolydiginone by an S. lydicus demethylase. Demethylation
activity, performed by family 51 of cytochrome P450s, of dif-
ferent structural types of bioactive compounds is widely dis-
tributed among actinomycetes and has been reported from
several Streptomyces and Mycobacterium species. In particular,
drug N demethylases have been reported from Streptomyces
griseus ATCC 13273 (5), Streptomyces platensis NRRL2364 (4),
and other Streptomyces spp. (11).
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